XML 32 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shareholders' Equity (Tables)
6 Months Ended
Jun. 30, 2013
Shareholders' Equity  
Share-Based Activity
  Three Months Ended Six Months Ended
  June 30, June 30,
  2013 2012 2013 2012
             
Share-based compensation expense $ 1,916 $ 1,620 $ 3,966 $ 3,412
Fair value of shares vested    1,318   477   10,500   6,425
Cash received from option exercises    8,037   4,151   13,728   6,672
Tax benefit from option exercises    922   450   1,210   529
Schedule Of Changes In Non-Vested Restricted Shares
      Weighted
    Number Average
    of Grant
    Shares Price
        
Non-vested shares at December 31, 2012  828,686 $ 22.50
 Shares granted   291,863   31.66
 Shares vested  (329,152)   21.34
 Shares forfeited   (16,343)   23.11
       
Non-vested shares at June 30, 2013  775,054 $ 26.44
Schedule Of Stock Option Activity
         Weighted
         Average
      Weighted Remaining
    Number Average Contractual
    of Exercise Term
    Shares Price (in years)
          
Outstanding at December 31, 2012  1,662,830 $ 23.82  2.9
 Options exercised with total intrinsic value of $13,728,000  (567,213)   24.20  
          
Outstanding at June 30, 2013 with aggregate intrinsic value of $12,571,000  1,095,617 $ 23.63  3.3
          
Vested at June 30, 2013 with aggregate intrinsic value of $12,571,000  1,095,617 $ 23.63  3.3
          
Exercisable at June 30, 2013 with aggregate intrinsic value of $12,571,000  1,095,617 $ 23.63  3.3
Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share
    Three Months Ended June 30,
         Per
    Earnings Shares  Share
    (Numerator) (Denominator) Amount
           
2013:        
Net earnings from continuing operations attributable to AmSurg Corp.        
  per common share (basic) $ 36,374  31,213 $ 1.17
           
Effect of dilutive securities options and non-vested shares    -   659   
           
 Net earnings from continuing operations attributable to AmSurg Corp.        
   per common share (diluted)  $ 36,374  31,872 $ 1.14
           
Net earnings attributable to AmSurg Corp. per common share (basic)  $ 36,374  31,213 $ 1.17
          
Effect of dilutive securities options and non-vested shares   -   659   
           
 Net earnings attributable to AmSurg Corp.        
   per common share (diluted) $ 36,374  31,872 $ 1.14
           
2012:        
Net earnings from continuing operations attributable to AmSurg Corp.        
  per common share (basic) $ 31,614  30,681 $ 1.03
           
Effect of dilutive securities options and non-vested shares    -   808   
           
 Net earnings from continuing operations attributable to AmSurg Corp.        
   per common share (diluted)  $ 31,614  31,489 $ 1.00
           
Net earnings attributable to AmSurg Corp. per common share (basic)  $ 30,312  30,681 $ 0.99
          
Effect of dilutive securities options and non-vested shares   -   808   
           
 Net earnings attributable to AmSurg Corp.        
   per common share (diluted) $ 30,312  31,489 $ 0.96